is tirzepatide still on the fda shortage list recent announcement that has been removed from the FDA's drug good news for people looking for effective weight loss solutions. But, it could mean the compounded versions FDA reconsidering its decision to

The comments from Cigna executives about GLP-1 coverage and utilization apply to health plans that use the companys pharmacy benefits manager, Express Scripts, to handle their prescription drug coverage

Cold medication stings more going in

The Bottom Line Two medications which are currently available include Qsymia (phentermine / topiramate ER) and Wegovy (semaglutide)

Clinical trials open doors to long-term health

Compounded medications vary in quality, consistency and composition, and theyre not subject to the same rigorous testing as FDA-approved formulations, said Korman

Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management in adults with obesity or overweight with weight-related comorbidities